From: Cerebral infarction in advanced non-small cell lung cancer: a case control study
Age ranges | Stage | Histology | Brain metastasis at diagnosis | Number of cerebral infarctions | Anticancer therapy | Chemotherapeutic regimen | D-dimer | Outcome | OS from CI (days) | |
---|---|---|---|---|---|---|---|---|---|---|
1 | 70s | IV | Ad | – | Multi | + | Erlotinib | 2.2 | Recover | 791 |
2 | 50s | rec | Ad | – | Multi | + | DTX | 5.6 | Recover | 341 |
3 | 60s | IV | Ad | + | Multi | + | CBDCA + PTX | 4.9 | Recover | 280 |
4 | 60s | IIIB | Sq | – | Multi | + | CBDCA + PTX | 4.6 | Recover | 161 |
5 | 70s | IV | Ad | + | Multi | + | Erlotinib | 24.7 | Recover | 125 |
6 | 60s | IV | Sq | + | Mono | + | RTx | 1.8 | Dead | 66 |
7 | 70s | IV | Ad | + | Multi | – | – | 37.8 | Recover | 44 |
8 | 40s | IV | Ad | + | Multi | + | Erlotinib | 10 | Dead | 36 |
9 | 50s | IV | Ad | + | Multi | + | Crizotinib | 46 | Dead | 32 |
10 | 60s | IV | La | + | Multi | + | DTX | 46.6 | Dead | 28 |
11 | 50s | IV | Ad | + | Mono | + | CDDP + PEM | 2.8 | Dead | 25 |
12 | 60s | rec | Ad | – | Mono | + | CBDCA + PTX | 60 | Recover | 17 |
13 | 70s | IV | Ad | + | Multi | + | RTx | 22.3 | Dead | 7 |
14 | 70s | IV | Ad | – | Mono | + | PEM | 141 | Dead | 1 |
15 | 50s | rec | Ad | + | Mono | + | CDDP + PEM | 11.3 | Dead | 1 |